Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Colombel

Showing results (331-340 of 368) with videos related to

Pageof 37
Sort By:
Alimentary Pharmacology & Therapeutics|June 30, 2015
Randomised clinical trial: a placebo-controlled study of intravenous golimumab induction therapy for ulcerative colitisP Rutgeerts, B G Feagan, C W Marano, et al.
Alimentary Pharmacology & Therapeutics|April 15, 2011
The changing pattern of Crohn's disease incidence in northern France: a continuing increase in the 10- to 19-year-old age bracket (1988-2007)V Chouraki, G Savoye, L Dauchet, et al.
Gastroenterology|March 7, 2001
Inflammatory bowel disease in spouses and their offspringD Laharie, S Debeugny, M Peeters, et al.
Alimentary Pharmacology & Therapeutics|April 28, 2016
Serologic microbial associated markers can predict Crohn's disease behaviour years before disease diagnosisR S Choung, F Princen, T P Stockfisch, et al.
Gut|February 10, 2009
Adalimumab for the treatment of fistulas in patients with Crohn's diseaseJ-F Colombel, D A Schwartz, W J Sandborn, et al.
Gut|November 25, 2003
A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitisH Tilg, H Vogelsang, O Ludwiczek, et al.
Mbio|September 22, 2016
Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn's DiseaseG Hoarau, P K Mukherjee, C Gower-Rousseau, et al.
Gastroenterology|September 1, 1996
Clinical characteristics of Crohn's disease in 72 familiesJ F Colombel, B Grandbastien, C Gower-Rousseau, et al.
Alimentary Pharmacology & Therapeutics|March 8, 2018
Bariatric surgery is associated with increased risk of new-onset inflammatory bowel disease: case series and national database studyR Ungaro, R Fausel, H L Chang, et al.
Alimentary Pharmacology & Therapeutics|May 26, 2018
Long-term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapyW J Sandborn, P Rutgeerts, C Gasink, et al.
Pageof 37

Showing results (331-340 of 368) with videos related to

Sort By:
Pageof 37
Alimentary Pharmacology & Therapeutics|June 30, 2015
Randomised clinical trial: a placebo-controlled study of intravenous golimumab induction therapy for ulcerative colitisP Rutgeerts, B G Feagan, C W Marano, et al.
Alimentary Pharmacology & Therapeutics|April 15, 2011
The changing pattern of Crohn's disease incidence in northern France: a continuing increase in the 10- to 19-year-old age bracket (1988-2007)V Chouraki, G Savoye, L Dauchet, et al.
Gastroenterology|March 7, 2001
Inflammatory bowel disease in spouses and their offspringD Laharie, S Debeugny, M Peeters, et al.
Alimentary Pharmacology & Therapeutics|April 28, 2016
Serologic microbial associated markers can predict Crohn's disease behaviour years before disease diagnosisR S Choung, F Princen, T P Stockfisch, et al.
Gut|February 10, 2009
Adalimumab for the treatment of fistulas in patients with Crohn's diseaseJ-F Colombel, D A Schwartz, W J Sandborn, et al.
Gut|November 25, 2003
A randomised placebo controlled trial of pegylated interferon alpha in active ulcerative colitisH Tilg, H Vogelsang, O Ludwiczek, et al.
Mbio|September 22, 2016
Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn's DiseaseG Hoarau, P K Mukherjee, C Gower-Rousseau, et al.
Gastroenterology|September 1, 1996
Clinical characteristics of Crohn's disease in 72 familiesJ F Colombel, B Grandbastien, C Gower-Rousseau, et al.
Alimentary Pharmacology & Therapeutics|March 8, 2018
Bariatric surgery is associated with increased risk of new-onset inflammatory bowel disease: case series and national database studyR Ungaro, R Fausel, H L Chang, et al.
Alimentary Pharmacology & Therapeutics|May 26, 2018
Long-term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapyW J Sandborn, P Rutgeerts, C Gasink, et al.
Pageof 37